文献速递神经肿瘤

埃尔德海姆-切斯特病颅底表现:病例系列与系统综述

Skull Base Manifestations of Erdheim-Chester Disease: A Case Series and Systematic Review.
PubMed 文献 · Neurosurgery · 2019-01-01

该系统综述联合单中心回顾性分析,纳入18项研究共20例及本机构7例颅底ECD患者,中位诊断年龄49岁,男女比4:1;常见表现包括复视、头痛、构音障碍和眩晕,常被误诊为脑膜瘤或神经鞘瘤;药物治疗为初始治疗,手术仅用于活检诊断或减容缓解占位效应,不能治愈。

要点

  • 颅底ECD常模仿脑膜瘤(33%)、三叉神经鞘瘤(8%)等更常见病变。
  • 常见症状为复视(48%)、头痛(30%)、构音障碍(22%)、眩晕或失衡(22%)。
  • 手术不能治愈,主要限于活检确诊和/或减容缓解占位效应。

核心结论

  • 孤立的颅底病变常模仿脑膜瘤或颅神经鞘瘤等更常见病理。
  • 药物治疗是症状性颅底疾病初始治疗,手术切除不能治愈,手术效用主要限于活检确诊和/或减容缓解占位效应。

研究设计与样本

  • 系统检索Scopus、Web of Science和PubMed从建库至2018年5月1日报告颅底ECD的文章,并回顾性分析作者机构自1996年1月1日以来治疗的所有患者以补充数据。
  • 共检索到465篇文章,18项研究总计20例患者符合纳入标准,机构回顾额外识别7例患者。
  • 汇总后中位诊断年龄49岁(四分位距42-58),男女比4:1。

主要发现

  • 患者常表现为复视(48%)、头痛(30%)、构音障碍(22%)、眩晕或失衡(22%)。
  • 也观察到三叉神经感觉减退(11%)、面神经麻痹(7%)、听力损失(7%)和三叉神经痛(7%)。
  • ECD常模仿脑膜瘤(33%)、三叉神经鞘瘤(8%)、神经结节病(8%)和颅底淋巴瘤(8%)。

关键数值与推荐

  • 中位诊断年龄49岁(四分位距42-58),男女比4:1。
  • 复视48%,头痛30%,构音障碍22%,眩晕或失衡22%。
  • 三叉神经感觉减退11%,面神经麻痹7%,听力损失7%,三叉神经痛7%。
  • 模仿脑膜瘤33%,三叉神经鞘瘤8%,神经结节病8%,颅底淋巴瘤8%。

临床怎么用

  • 药物治疗是症状性颅底疾病的初始治疗。
  • 手术切除不能治愈,手术效用主要限于活检确诊和/或减容缓解占位效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Erdheim-Chester disease (ECD) is a rare, non-Langerhans cell histiocytosis. Up to 50% of patients develop central nervous system involvement, and a subset of these patients can present with isolated tumor-like masses. OBJECTIVE: To describe the skull base manifestations of ECD with an emphasis on aspects most pertinent to surgeons who may be referred such patients for primary evaluation. METHODS: Scopus, Web of Science, and PubMed were searched from database inception to May 1, 2018 for articles reporting skull base ECD. An institutional retrospective analysis of all patients treated at the authors' institution since January 1, 1996 was also performed to supplement these data. RESULTS: Of 465 retrieved articles, 18 studies totaling 20 patients met inclusion criteria. Institutional review identified an additional 7 patients. Collectively, the median age at diagnosis was 49 yr (interquartile range, 42-58) with a 4:1 male-to-female ratio. Patients frequently presented with diplopia (48%), headache (30%), dysarthria (22%), and vertigo or imbalance (22%), though trigeminal hypesthesia (11%), facial nerve paresis (7%), hearing loss (7%), and trigeminal neuralgia (7%) were also observed. ECD commonly mimicked meningioma (33%), trigeminal schwannoma (8%), neurosarcoidosis (8%), and skull base lymphoma (8%). CONCLUSION: Discrete skull base lesions frequently mimic more common pathology such as meningioma or cranial nerve schwannomas. Medical therapy comprises the initial treatment for symptomatic skull base disease. Surgical resection is not curative and the utility of surgical intervention is largely limited to biopsy to establish diagnosis and/or surgical debulking to relieve mass effect.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Marinelli JP, Peters PA, Vaglio A, et al. Skull Base Manifestations of Erdheim-Chester Disease: A Case Series and Systematic Review. Neurosurgery. 2019. PMID: 30828728. doi:10.1093/neuros/nyz027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。